(Reuters) Apr 3, 2018 - In record time, Loxo Oncology developed a novel drug for a wide variety of tumors that share a rare mutation. It recently struck a partnership with Germany’s Bayer. Its stock tripled in the past year.

(Cancer Research UK) Mar 28, 2018 - Chemotherapy courses after surgery could be cut in half for some colon cancer patients, according to a new global study.